Literature DB >> 19079649

Stem cells might participate in the cell turnover of duodenal adenomas.

Carlos A Rubio1.   

Abstract

Eighty-three duodenal adenomas were stained with hematoxylin-eosin (H&E) and with anti-lysozyme immunostain. Mature Paneth cells were those showing coarse brightly red cytoplasmic granules in H&E stain and Paneth cell precursors were those lysozyme-expressing cells that had remained undetected in H&E stain. In the adenomas, the number of mature Paneth cells/high power field varied from 4 to 12 (mean 6.5) in H&E stain, and of lysozyme-expressing cells from 32 to 62 (mean 46.5) (p<0.05). Lysozyme-expressing cells were found haphazardly distributed within the histological profile of the lesion, even in the most superficial cell layer of the dysplastic glands. The latter suggests that if the innate programmed vector of cell migration were valid for duodenal adenomas (from stem cells towards the bottom of the crypts for Paneth cells) the stem cells, normally overlaying Paneth cells, would have been exfoliated into the lumen. Another, less likely option, is that mutated stem cells at the bottom of duodenal adenomas translocate, in an unprecedented manner, the ontogenic signals of migration for Paneth cells. This stochastic molecular option would imply a total reversal of the normal migratory vector for Paneth cells, to a more aberrant, paradoxical migration flow, from stem cells to the villus domain, before exfoliation. Because of the unique migratory direction of the Paneth cells in the crypts of Lieberkühn, the duodenal adenoma emerges as a suitable histo-biological model to monitor the fate of stem cells. It is suggested that stem cells, together with the other recordable mature cells, namely dysplastic enterocytes, Paneth cells and goblet cells, participate in the cell turnover of duodenal adenomas. Further studies are necessary to definitively validate the abovementioned suggested hypothesis.

Entities:  

Keywords:  Duodenum; Paneth cells; adenomas; migration; stem cells; turnover

Year:  2008        PMID: 19079649      PMCID: PMC2583632     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  17 in total

1.  A Paneth cell surrogate?

Authors:  C A Rubio
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  A simple method to demonstrate normal and metaplastic Paneth cells in tissue sections.

Authors:  C A Rubio; G Nesi
Journal:  In Vivo       Date:  2003 Jan-Feb       Impact factor: 2.155

Review 3.  Paneth cells: leukocyte-like mediators of innate immunity in the intestine.

Authors:  Satish Keshav
Journal:  J Leukoc Biol       Date:  2006-06-22       Impact factor: 4.962

4.  Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin.

Authors:  Xunwei Wu; Fabio Quondamatteo; Tine Lefever; Aleksandra Czuchra; Hannelore Meyer; Anna Chrostek; Ralf Paus; Lutz Langbein; Cord Brakebusch
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

5.  A method of quantitating Paneth cell metaplasia of the stomach by image analysis.

Authors:  C A Rubio; A Porwit-McDonald; M Rodensjö; A Duvander
Journal:  Anal Quant Cytol Histol       Date:  1989-04       Impact factor: 0.302

6.  The Paneth cell in disease.

Authors:  K Lewin
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

7.  Gastric duodenal metaplasia in duodenal adenomas.

Authors:  C A Rubio
Journal:  J Clin Pathol       Date:  2006-07-12       Impact factor: 3.411

8.  Activation of Paneth cell alpha-defensins in mouse small intestine.

Authors:  Tokiyoshi Ayabe; Donald P Satchell; Patrizia Pesendorfer; Hiroki Tanabe; Carole L Wilson; Susan J Hagen; Andre J Ouellette
Journal:  J Biol Chem       Date:  2001-12-03       Impact factor: 5.157

Review 9.  Wnt signaling inside the nucleus.

Authors:  Miki Shitashige; Setsuo Hirohashi; Tesshi Yamada
Journal:  Cancer Sci       Date:  2008-01-02       Impact factor: 6.716

10.  Do stem cells participate in cell turnover in duodenal adenomas? A preliminary study on Paneth cells.

Authors:  Carlos A Rubio
Journal:  Anticancer Res       Date:  2008 May-Jun       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.